Congress Unanimously Passes Life-Saving Stem Cell Therapeutic and Research Reauthorization Bill

Press Release

Today, the U.S. House of Representatives unanimously passed the Senate-amended version of H.R. 2820, the Stem Cell Therapeutic and Research Reauthorization Act, a bill co-authored by Congresswoman Doris Matsui (D-CA) that will reauthorize the C.W. Bill Young Cell Transplantation Program and the National Cord Blood Inventory (NCBI). H.R. 2820 will renew federal funding for the vital national bone marrow and cord blood registry and coordinating centers, which facilitate bone marrow and cord blood donations that provide transplants to treat diseases like blood cancer, sickle cell anemia, and inherited metabolic or immune system disorders.

"Passage of the Stem Cell Therapeutic and Research Reauthorization Act provides hope to the thousands of Americans and their families who suffer from painful and potentially life-threatening blood cancer or other bone marrow disorders," said Congresswoman Matsui, Co-Chair of the Congressional Caucus to Cure Blood Cancers and Other Blood Disorders. "The "Be a Match' National Registry makes possible life-saving transplants by connecting patients with donors, and funding the services and research needed to eradicate these devastating diseases."

Source